Suppr超能文献

[俄罗斯医患互动与动脉高血压控制问题。ARGUS - 2科学实践项目的主要成果]

[Problems of a physician-patient interaction and control of arterial hypertension in Russia. Main results of scientific-practical program ARGUS-2].

作者信息

Kobalava Zh D, Kotovskaia Iu V, Starostina E G, Villeval'de S V, Luk'ianova E A, Serebrennikovca O N, Maslova I M, Baranova E I, Bogachev R S, Volkova N I, Drozdetskiĭ S I, Kisliak O A, Koziolova N A, Kolina I G, Krasnova Iu N, Lopatin Iu M, Nedogoda S V, Tarlovskaia E I, Tiukalova L I, Khokhlov R A, Freĭdlina M A

出版信息

Kardiologiia. 2007;47(3):38-47.

Abstract

OBJECTIVE

To study the problems of physician-patient cooperation, patient- and physician related barrieres to target blood pressure (BP) achievement and to demonstrate improvement of BP control with indapamide SR 1.5 mg, when given to patients remaining uncontrolled while receiving antihypertensive therapy without thiazide diuretics (TD).

METHODS

The trial Improvement of Arterial Hypertension Control in High-Risk Hypertensive Patients (ARGUS-2) run in 15 Russian centres during the year 2006. Retrospective analysis of medical notes of 684 outpatients and 575 inpatients with arterial hypertension. Validated questionnaires were used for interview of 373 physicians and 1298 patients. The study of Arifon retard efficacy was carried out in 1438 outpatients with difficult-to-control hypertension.

RESULTS

BP was above the goal level in 97.1% pts at the first analyzed visit to an outpatient department. Antihypertensive therapy was unchanged in 20.5% cases, the drug dose was increased in 46,6%, additional medication was administered in 36,8%. In 30.8% pts antihypertensive agent was substituted by another class drug. At the last analyzed visit target BP was found in 24.4% pts. BP control was poorer in pts with BP goal <130/80 mmHg (20.1%) than in those with higher target BP (25.9%). Achievement of BP goal was associated with combination therapy, higher rate of TD administration and with more frequent visits to physician. During hospitalization target BP <140/<90 mmHg was achieved in 87.1%,<130/<80 mmHg in. 76.2%. Arifon retard administration resulted in target BO achievement in 84.5% patients. Physicians percept low adherence to antihypertensive treatment, lack of patients knowledge about risk related to arterial hypertension, economical problems as main barriers to improvement of arterial hypertension management. Patients considered economical problems related to antihypertensive treatment more much less important than physicians did.

CONCLUSION

The study results suggest the importance of therapeutic inertia overcome to improve arterial hypertension management in Russia. Low rate of multiple combination therapy and TD prescription are important features of therapeutic inertia. Polar perception of problems related to arterial hypertension by physicians and patients should be considered as influencing factors for educational programs development.

摘要

目的

研究医患合作问题、患者及医生方面影响目标血压达成的障碍,并证明对于在接受不含噻嗪类利尿剂(TD)的抗高血压治疗时血压仍未得到控制的患者,给予1.5毫克缓释吲达帕胺可改善血压控制情况。

方法

2006年在俄罗斯15个中心开展了高危高血压患者动脉高血压控制改善试验(ARGUS - 2)。对684例门诊患者和575例住院动脉高血压患者的病历进行回顾性分析。使用经过验证的问卷对373名医生和1298例患者进行访谈。对1438例难治性高血压门诊患者进行了阿利芬缓释片疗效研究。

结果

在首次分析的门诊就诊时,97.1%的患者血压高于目标水平。20.5%的病例抗高血压治疗未改变,46.6%的病例增加了药物剂量,36.8%的病例加用了其他药物。30.8%的患者将抗高血压药物换为另一类药物。在最后一次分析就诊时,24.4%的患者达到了目标血压。血压目标为<130/80 mmHg的患者血压控制情况(20.1%)比目标血压更高的患者(25.9%)更差。血压目标的达成与联合治疗、更高的TD给药率以及更频繁的就诊有关。住院期间,87.1%的患者实现了目标血压<140/<90 mmHg,76.2%的患者实现了目标血压<130/<80 mmHg。给予阿利芬缓释片后,84.5%的患者实现了目标血压。医生认为患者对抗高血压治疗的依从性低、患者缺乏与动脉高血压相关风险的知识以及经济问题是改善动脉高血压管理的主要障碍。患者认为与抗高血压治疗相关的经济问题远没有医生认为的那么重要。

结论

研究结果表明,在俄罗斯克服治疗惰性对于改善动脉高血压管理很重要。联合治疗率低和TD处方率低是治疗惰性 的重要特征。医生和患者对动脉高血压相关问题的两极化认知应被视为制定教育计划的影响因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验